<DOC>
	<DOCNO>NCT00555555</DOCNO>
	<brief_summary>To assess efficacy FVIII/VWF Complex ( Human ) , Alphanate速 replacement therapy prevent excessive bleeding subject congenital Type 3 von Willebrand Disease ( VWD ) undergo surgical procedure .</brief_summary>
	<brief_title>Efficacy Alphanate FVIII/VWF Concentrate Type 3 Von Willebrand Patients</brief_title>
	<detailed_description>For treatment surgical procedure intend dose Alphanate速 give single dose multiple dos several day , depend clinical situation , accord Full Prescribing Information guideline investigator 's judgment . For treated event , subject 's treatment period finish , opinion local Investigator , participate subject would benefit infusion study concentrate .</detailed_description>
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>1 . Male female 7 year age old 2 . The subject diagnose inherited VWD Type 3 determine subject 's medical record . 3 . The subject need surgical procedure ( least 10 surgical procedure consider `` Major '' accord criterion protocol ) . 4 . The subject expect respond exogenously administer FVIII/VWF accord Investigator 's judgment . 5 . The subject freely give write informed consent . Patients legally permit provide write consent must sign form assent study participation , write consent must provide parent legal guardian . 1 . The subject diagnose acquire VWD . 2 . The subject known history intolerance Alphanate速 contain substance . 3 . The subject known history anaphylactic reaction ( ) blood blood component . 4 . Liver function test ( AST , ALT , bilirubin ) &gt; 2.5 x upper limit normal ( ULN ) . 5 . Renal function test ( creatinine , BUN ) &gt; 1.5 x ULN . 6 . The subject know suspected present past inhibitor activity ( antibody ) direct FVIII VWF . 7 . The subject know abuse alcohol illicit drug use within past 12 month . 8 . The subject participate another clinical study involve investigational treatment , participate within past 4 week ( except patient participate another Alphanate速 study ) . Studies consist data blood sample collection regular longterm basis exempt exclusion . 9 . The subject unlikely adhere protocol requirement study .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Factor VIII deficiency</keyword>
	<keyword>Von Willebrand disease</keyword>
	<keyword>FVIII/VWF concentrate</keyword>
	<keyword>Bleeding disorder</keyword>
	<keyword>Blood disorder</keyword>
</DOC>